Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
3 NC counties are under alert, including Johnston County.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Angion Biomedica Corp
(NQ:
ANGN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 1, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
0.8900 (1)
Ask (Size)
1.090 (10)
Prev. Close
1.000
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
29,798,399
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
June 01, 2023
From
Angion Biomedica Corp.
Via
GlobeNewswire
Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 26, 2023
Gainers Onfolio Holdings, Inc. (NASDAQ: ONFO) gained 73% to $2.02 after the company announced it completed development of a generative AI search tool.
Via
Benzinga
Performance
More News
Read More
Why Gap Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
May 26, 2023
Via
Benzinga
Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 23, 2023
Via
Benzinga
Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 18, 2023
Via
Benzinga
Why Levi Strauss Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 06, 2023
Via
Benzinga
Why Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 29, 2023
Via
Benzinga
ANGN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Angion Biomedica Corp. Is Fair to Shareholders
February 27, 2023
From
Halper Sadeh LLC
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sumo Logic (Nasdaq – SUMO), Angion Biomedica Corp (Nasdaq - ANGN), TravelCenters of America Inc. (Nasdaq - TA), IAA, Inc. (NYSE - IAA)
February 22, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Tuesday
March 21, 2023
Via
Benzinga
ANGION BIOMEDICA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Angion Biomedica Corp - ANGN
January 19, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Stocks That Hit 52-Week Lows On Wednesday
January 18, 2023
Via
Benzinga
Nasdaq Edges Higher; Neovasc Shares Jump
January 17, 2023
Via
Benzinga
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 17, 2023
Via
Benzinga
Dow Tumbles 300 Points; Morgan Stanley Beats Q4 Views
January 17, 2023
Via
Benzinga
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Angion Biomedica Corp (Nasdaq - ANGN)
January 17, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
January 17, 2023
Via
InvestorPlace
ANGN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Angion Biomedica Corp. Is Fair to Shareholders
January 17, 2023
From
Halper Sadeh LLC
Via
Business Wire
Elicio Therapeutics and Angion Enter into Definitive Merger Agreement
January 17, 2023
From
Angion Biomedica Corp.
Via
GlobeNewswire
Angion Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
December 21, 2022
From
Angion Biomedica Corp.
Via
GlobeNewswire
Angion Biomedica's Return On Capital Employed Overview
September 12, 2022
Via
Benzinga
Recap: Angion Biomedica Q2 Earnings
August 15, 2022
Via
Benzinga
Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate
July 26, 2022
Via
Benzinga
Angion Announces Process to Explore Strategic Alternatives for Enhancing and Preserving Shareholder Value
July 25, 2022
From
Angion Biomedica Corp.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
July 25, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.